Investigated event: Influence on protein activity - MAPK signalling

Name Value
Compound Napabucasin
Investigated event Influence on protein activity - MAPK signalling
Experiment type Western Blot
Concentration 1.50 µM
Cell line SUDHL-4
Organism Homo sapiens
Animal model
STAT protein
Other p-p38
Reference
Napabucasin, a novel inhibitor of STAT3, inhibits growth and synergises with doxorubicin in diffuse large B-cell lymphoma. Cancer letters Xue Li, Yuquan Wei, Xiawei Wei, 491, None, 2020-10-28, 2020-08-14, 10.1016/j.canlet.2020.07.032 DOI: 10.1016/j.canlet.2020.07.032 PUBMED: 32798587 PMCID: 32798587